Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

NCT04079413 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: GP40071
DRUG: NovoRapid® Penfill®

Sponsor

Geropharm